Binding Kinetics of Glucose and Allosteric Activators to Human Glucokinase Reveal Multiple Conformational States

被引:47
作者
Antoine, Mathias [1 ]
Boutin, Jean A. [1 ]
Ferry, Gilles [1 ]
机构
[1] Inst Rech Servier, Div Pharmacol Mol & Cellulaire, F-78290 Croissy Sur Seine, France
关键词
LIVER GLUCOKINASE; PROTEIN; INHIBITION; METABOLISM; TRANSITION; MECHANISM; MUTATION; SENSOR;
D O I
10.1021/bi900374c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Slow conformational changes have been proposed to be responsible for the kinetic positive cooperativity of glucokinase (GK) with glucose. Induced-fit and preexisting equilibrium kinetic models have been previously suggested. In the present study, equilibrium and pre-steady-state fluorescence spectroscopy has been used to resolve those conflicting reports. Multiphasic transients were observed after rapid mixing of apo-GK with glucose. Progress curve analysis revealed inconsistencies with the induced-fit model. The glucose dependence of the major kinetic phase supported the preexistence of at least two slowly interconverting GK conformers. In the absence of glucose, approximate to 80% of the GK population is likely poised in a largely open conformation (K-D approximate to 30 mM). The remaining 20% is in a more compact conformation (K-D approximate to 0.2 mM). Transients revealed three additional phases likely reflecting intermediates on the pathway between the superopen and the closed conformer. Using an intrinsically fluorescent GK activator (GKA), it was shown that GK can bind GKA in the absence of glucose, confirming the validity of the preexisting equilibrium model. Additionally, a perturbation of the GKA binding kinetic parameters after preequilibration of closed GK with an ATP analogue suggested a local rearrangement of the allosteric site upon nucleotide binding. Our data suggest that, in the absence of any ligand, GK might be able to extensively sample the conformational space delimited by the superopen and the closed conformations. The complex GK conformational equilibrium is readily shifted upon binding of ligands such as glucose or GKAs on specific GK conformers.
引用
收藏
页码:5466 / 5482
页数:17
相关论文
共 33 条
  • [1] Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis
    Agius, L
    Peak, M
    Newgard, CB
    GomezFoix, AM
    Guinovart, JJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) : 30479 - 30486
  • [2] Biophysical Characterization of the Interaction between Hepatic Glucokinase and Its Regulatory Protein IMPACT OF PHYSIOLOGICAL AND PHARMACOLOGICAL EFFECTORS
    Anderka, Oliver
    Boyken, Janina
    Aschenbach, Ursula
    Batzer, Andreas
    Boscheinen, Oliver
    Schmoll, Dieter
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) : 31333 - 31340
  • [3] Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library - Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner
    Baltrusch, S
    Lenzen, S
    Okar, DA
    Lange, AJ
    Tiedge, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) : 43915 - 43923
  • [4] Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators
    Brocklehurst, KJ
    Payne, VA
    Davies, RA
    Carroll, D
    Vertigan, HL
    Wightman, HJ
    Aiston, S
    Waddell, ID
    Leighton, B
    Coghlan, MP
    Agius, L
    [J]. DIABETES, 2004, 53 (03) : 535 - 541
  • [5] Glucokinase-activating ureas
    Castelhano, AL
    Dong, HQ
    Fyfe, MCT
    Gardner, LS
    Kamikozawa, Y
    Kurabayashi, S
    Nawano, M
    Ohashi, R
    Procter, MJ
    Qiu, L
    Rasamison, CM
    Schofield, KL
    Shah, VK
    Ueta, K
    Williams, GM
    Witter, D
    Yasuda, K
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1501 - 1504
  • [6] The second activating glucokinase mutation (A456V) - Implications for glucose homeostasis and diabetes therapy
    Christesen, HBT
    Jacobsen, BB
    Odili, S
    Buettger, C
    Cuesta-Munoz, A
    Hansen, T
    Brusgaard, K
    Massa, O
    Magnuson, MA
    Shiota, C
    Matschinsky, FM
    Barbetti, F
    [J]. DIABETES, 2002, 51 (04) : 1240 - 1246
  • [7] Cornish-Bowden A, 2004, FRONT DIABETES, V16, P125
  • [8] Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation
    Cuesta-Muñoz, AL
    Huopio, H
    Otonkoski, T
    Gomez-Zumaquero, JM
    Näntö-Salonen, K
    Rahier, J
    López-Enriquez, S
    García-Gimeno, MA
    Sanz, P
    Soriguer, FC
    Laakso, M
    [J]. DIABETES, 2004, 53 (08) : 2164 - 2168
  • [9] A novel glucokinase activator modulates pancreatic islet and hepatocyte function
    Efanov, AM
    Barrett, DG
    Brenner, MB
    Briggs, SL
    Delaunois, A
    Durbin, JD
    Giese, U
    Guo, HH
    Radloff, M
    Gil, GS
    Sewing, S
    Wang, Y
    Weichert, A
    Zaliani, A
    Gromada, J
    [J]. ENDOCRINOLOGY, 2005, 146 (09) : 3696 - 3701
  • [10] Allosteric activators of glucokinase: Potential role in diabetes therapy
    Grimsby, J
    Sarabu, R
    Corbett, WL
    Haynes, NE
    Bizzarro, FT
    Coffey, JW
    Guertin, KR
    Hilliard, DW
    Kester, RF
    Mahaney, PE
    Marcus, L
    Qi, LD
    Spence, CL
    Tengi, J
    Magnuson, MA
    Chu, CA
    Dvorozniak, MT
    Matschinsky, FM
    Grippo, JF
    [J]. SCIENCE, 2003, 301 (5631) : 370 - 373